Moitreyee Chatterjee-kishore PhD, MBA

Moitreyee Chatterjee-Kishore, Ph.D., MBA is a Compound Development Team Leader at Janssen Oncology. In this position she is responsible for a developing a portfolio of early development cancer immunotherapy assets from late discovery through market authorization. Prior to this position she was an Early Pipeline Lead for Oncology and Immunology programs at Abbvie. She has more than 15 years’ experience in the development of large molecules including bi-specifics, antibody-drug conjugates and other novel scaffolds.